As filed with the Securities and Exchange Commission on May 17, 2018.
Registration Nos. 333-224185 and 333-224984
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
CESCA THERAPEUTICS INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
3821 |
|
94-3018487 |
|
(State or other jurisdiction of |
|
(Primary Standard Industrial |
|
(I.R.S. Employer |
2711 Citrus Road
Rancho Cordova, California 95742
(916) 858-5100
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Vivian Liu
Chief Operating Officer
2711 Citrus Road
Rancho Cordova, California 95742
(916) 858-5100
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
|
Curt P. Creely, Esq. |
Jeffrey Fessler, Esq. |
|
John Wolfel, Esq. |
Sheppard Mullin Richter & Hampton LLP |
|
Foley & Lardner LLP |
30 Rockefeller Plaza, 39th Floor |
|
100 North Tampa Street, Suite 2700 |
New York, New York 10112 |
|
Tampa, Florida 33602 |
Phone: (212) 653-8700 |
|
Phone: (813) 229-2300 |
Fax: (212) 653-8701 |
|
Fax: (813) 221-4210 |
|
Approximate date of commencement of proposed sale to the public:
As soon as practicable after this Registration Statement is declared effective.
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended, check the following box: ☒
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ (Registration Nos. 333-224185 and 333-224984)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer |
☐ |
|
Accelerated filer |
☐ |
|
Non-accelerated filer |
☐ |
(Do not check if a smaller reporting company) |
Smaller reporting company |
☒ |
|
Emerging growth company |
☐ |
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
This post-effective amendment shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(d) under the Securities Act of 1933, as amended.
EXPLANATORY NOTE
This Post-Effective Amendment No. 1 (this “Amendment”) relates to the Registrant’s Registration Statement on Form S-1 (File No. 333-224185), as amended, declared effective on May 16, 2018 by the Securities and Exchange Commission. The Registrant is filing this Amendment for the sole purpose of replacing Exhibit 5.1 to the Registration Statement. This Amendment does not modify any provisions of Part I or Part II of the Registration Statement other than Item 16(a).
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 16. Exhibits and Financial Statement Schedules.
(a) Exhibits.
|
Exhibit No. |
Document Description |
|
5.1 |
|
|
23.3 |
|
|
24.1 |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Post-Effective Amendment No. 1 to Registration Statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Rancho Cordova, State of California, on this 17th day of May, 2018.
|
|
Cesca Therapeutics Inc. |
|
|
|
|
|
|
|
By: |
/s/ Xiaochun Xu |
|
|
|
Xiaochun “Chris” Xu, Chief Executive Officer |
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
|
Signature |
|
Title |
|
Date |
|
|
|
|
|
|
|
/s/ Xiaochun Xu |
|
Chief Executive Officer and Chairman of the Board |
|
May 17, 2018 |
|
Xiaochun “Chris” Xu |
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
|
|
/s/ Jeff Cauble |
|
Principal Financial and Accounting Officer |
|
May 17, 2018 |
|
Jeff Cauble |
|
(Principal Financial Officer and Principal Accounting Officer) |
|
|
|
|
|
|
|
|
|
/s/ Vivian Liu |
|
Chief Operating Officer and Director |
|
May 17, 2018 |
|
Vivian Liu |
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
May 17, 2018 |
|
Russell Medford |
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
May 17, 2018 |
|
Joseph Thomis |
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
May 17, 2018 |
|
Mark Westgate |
|
|
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
May 17, 2018 |
|
James Xu |
|
|
|
|
*By: /s/ Xiaochun Xu
Xiaochun “Chris” Xu, as attorney-in-fact